Poland· PL-100026752
Ginkofar
A ginkgoblatt product containing ginkgo bilobae folii extractum, registered in Poland by Biofarm Sp. z o.o.. The same ATC class is registered in 6 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Ginkgoblatt is registered in 6 of 19 countries.
Countries holding a registration under ATC N06DX02 (ginkgoblatt), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 5 of them publish a price we can compare per daily dose
Ginkgoblatt · ATC N06DX02
6 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Polandprice
- Spainprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Ginkgo bilobae folii extractum
- Manufacturer
- Biofarm Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- N06DX02
- ATC class
- Ginkgoblatt
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 4
- gtin05909990677023
- gtin05909990677030
- gtin05909990695461
- gtin05909990677016
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
22 interactions on record for ginkgoblatt.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ginkgoblatt · interactions on record
22 records
22 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame class
Other records under N06DX02
Ginkgoblatt, as other registers publish it.
- PolandBilobil ForteKrka, d.d., Novo mesto
- PolandBilobil IntenseKrka, d.d., Novo mesto
- PolandBilomagNatur Produkt Pharma Sp. z o.o.
- DenmarkBio-BilobaPharma Nord ApS
- BelgiumFocuzine 120Dr. Willmar Schwabe
- BelgiumFocuzine 40Dr. Willmar Schwabe
- CzechiaGINGIOSandoz s.r.o., Praha
- CzechiaGINGIOSandoz s.r.o., Praha
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e3dadde7-5b00-4525-9657-a5353ad73138 GET /v1/drugs/e3dadde7-5b00-4525-9657-a5353ad73138?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "40 mg",
"packaging": "05909990677023 ¦ OTC ¦ 4291\n60 tabl.\n05909990677030 ¦ OTC ¦ Skasowane ¦ 13815\n90 tabl. w blistrach (9 x 10)\n05909990695461 ¦ OTC ¦ 49681\n90 tabl.\n05909990677016 ¦ OTC ¦ 51774\n20 tabl.",
"substance": "Ginkgo bilobae extractum (35-67:1) 40 mg",
"common_name": "Ginkgo bilobae folii extractum",
"pl_product_id": "100026752",
"pozwolenie_nr": "06770",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about ginkgoblatt.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.